50,616 research outputs found

    Cross-layer design of multi-hop wireless networks

    Get PDF
    MULTI -hop wireless networks are usually defined as a collection of nodes equipped with radio transmitters, which not only have the capability to communicate each other in a multi-hop fashion, but also to route each others’ data packets. The distributed nature of such networks makes them suitable for a variety of applications where there are no assumed reliable central entities, or controllers, and may significantly improve the scalability issues of conventional single-hop wireless networks. This Ph.D. dissertation mainly investigates two aspects of the research issues related to the efficient multi-hop wireless networks design, namely: (a) network protocols and (b) network management, both in cross-layer design paradigms to ensure the notion of service quality, such as quality of service (QoS) in wireless mesh networks (WMNs) for backhaul applications and quality of information (QoI) in wireless sensor networks (WSNs) for sensing tasks. Throughout the presentation of this Ph.D. dissertation, different network settings are used as illustrative examples, however the proposed algorithms, methodologies, protocols, and models are not restricted in the considered networks, but rather have wide applicability. First, this dissertation proposes a cross-layer design framework integrating a distributed proportional-fair scheduler and a QoS routing algorithm, while using WMNs as an illustrative example. The proposed approach has significant performance gain compared with other network protocols. Second, this dissertation proposes a generic admission control methodology for any packet network, wired and wireless, by modeling the network as a black box, and using a generic mathematical 0. Abstract 3 function and Taylor expansion to capture the admission impact. Third, this dissertation further enhances the previous designs by proposing a negotiation process, to bridge the applications’ service quality demands and the resource management, while using WSNs as an illustrative example. This approach allows the negotiation among different service classes and WSN resource allocations to reach the optimal operational status. Finally, the guarantees of the service quality are extended to the environment of multiple, disconnected, mobile subnetworks, where the question of how to maintain communications using dynamically controlled, unmanned data ferries is investigated

    Thirty Years of Machine Learning: The Road to Pareto-Optimal Wireless Networks

    Full text link
    Future wireless networks have a substantial potential in terms of supporting a broad range of complex compelling applications both in military and civilian fields, where the users are able to enjoy high-rate, low-latency, low-cost and reliable information services. Achieving this ambitious goal requires new radio techniques for adaptive learning and intelligent decision making because of the complex heterogeneous nature of the network structures and wireless services. Machine learning (ML) algorithms have great success in supporting big data analytics, efficient parameter estimation and interactive decision making. Hence, in this article, we review the thirty-year history of ML by elaborating on supervised learning, unsupervised learning, reinforcement learning and deep learning. Furthermore, we investigate their employment in the compelling applications of wireless networks, including heterogeneous networks (HetNets), cognitive radios (CR), Internet of things (IoT), machine to machine networks (M2M), and so on. This article aims for assisting the readers in clarifying the motivation and methodology of the various ML algorithms, so as to invoke them for hitherto unexplored services as well as scenarios of future wireless networks.Comment: 46 pages, 22 fig

    A systematic review of the role of bisphosphonates in metastatic disease

    Get PDF
    Objectives: To identify evidence for the role of bisphosphonates in malignancy for the treatment of hypercalcaemia, prevention of skeletal morbidity and use in the adjuvant setting. To perform an economic review of current literature and model the cost effectiveness of bisphosphonates in the treatment of hypercalcaemia and prevention of skeletal morbidity Data sources: Electronic databases (1966-June 2001). Cochrane register. Pharmaceutical companies. Experts in the field. Handsearching of abstracts and leading oncology journals (1999-2001). Review methods: Two independent reviewers assessed studies for inclusion, according to predetermined criteria, and extracted relevant data. Overall event rates were pooled in a meta-analysis, odds ratios ( OR) were given with 95% confidence intervals (CI). Where data could not be combined, studies were reported individually and proportions compared using chi- squared analysis. Cost and cost-effectiveness were assessed by a decision analytic model comparing different bisphosphonate regimens for the treatment of hypercalcaemia; Markov models were employed to evaluate the use of bisphosphonates to prevent skeletal-related events (SRE) in patients with breast cancer and multiple myeloma. Results: For acute hypercalcaemia of malignancy, bisphosphonates normalised serum calcium in >70% of patients within 2-6 days. Pamidronate was more effective than control, etidronate, mithramycin and low-dose clodronate, but equal to high dose clodronate, in achieving normocalcaemia. Pamidronate prolongs ( doubles) the median time to relapse compared with clodronate or etidronate. For prevention of skeletal morbidity, bisphosphonates compared with placebo, significantly reduced the OR for fractures (OR [95% CI], vertebral, 0.69 [0.57-0.84], non-vertebral, 0.65 [0.54-0.79], combined, 0.65 [0.55-0.78]) radiotherapy 0.67 [0.57-0.79] and hypercalcaemia 0.54 [0.36-0.81] but not orthopaedic surgery 0.70 [0.46-1.05] or spinal cord compression 0.71 [0.47-1.08]. However, reduction in orthopaedic surgery was significant in studies that lasted over a year 0.59 [0.39-0.88]. Bisphosphonates significantly increased the time to first SRE but did not affect survival. Subanalyses were performed for disease groups, drugs and route of administration. Most evidence supports the use of intravenous aminobisphosphonates. For adjuvant use of bisphosphonates, Clodronate, given to patients with primary operable breast cancer and no metastatic disease, significantly reduced the number of patients developing bone metastases. This benefit was not maintained once regular administration had been discontinued. Two trials reported significant survival advantages in the treated groups. Bisphosphonates reduce the number of bone metastases in patients with both early and advanced breast cancer. Bisphosphonates are well tolerated with a low incidence of side-effects. Economic modelling showed that for acute hypercalcaemia, drugs with the longest cumulative duration of normocalcaemia were most cost-effective. Zoledronate 4 mg was the most costly, but most cost-effective treatment. For skeletal morbidity, Markov models estimated that the overall cost of bisphosphonate therapy to prevent an SRE was pound250 and pound1500 per event for patients with breast cancer and multiple myeloma, respectively. Bisphosphonate treatment is sometimes cost-saving in breast cancer patients where fractures are prevented. Conclusions: High dose aminobisphosphonates are most effective for the treatment of acute hypercalcaemia and delay time to relapse. Bisphosphonates significantly reduce SREs and delay the time to first SRE in patients with bony metastatic disease but do not affect survival. Benefit is demonstrated after administration for at least 6-12 months. The greatest body of evidence supports the use of intravenous aminobisphosphonates. Further evidence is required to support use in the adjuvant setting

    Social health insurance

    Get PDF

    Public health training in Europe. Development of European masters degrees in public health.

    Get PDF
    BACKGROUND: Changing political and economic relations in Europe mean that there are new challenges for public health and public health training. There have been several attempts to develop training at the master's level in public health which is focused on meeting the new needs. These have failed due to being too inflexible to allow participation by schools of public health. METHODS: A project funded by the European Union involving public health trainers has developed a new approach which allows participating schools to retain their national differences and work within local rules and traditions, but which aims to introduce the European dimension into public health training. This paper reports the conclusions of this project. CONCLUSIONS: A network of schools wishing to develop European Master's degrees is being established and other schools offering good quality programmes will be able to join

    Fuzzy Interval-Valued Multi Criteria Based Decision Making for Ranking Features in Multi-Modal 3D Face Recognition

    Get PDF
    Soodamani Ramalingam, 'Fuzzy interval-valued multi criteria based decision making for ranking features in multi-modal 3D face recognition', Fuzzy Sets and Systems, In Press version available online 13 June 2017. This is an Open Access paper, made available under the Creative Commons license CC BY 4.0 https://creativecommons.org/licenses/by/4.0/This paper describes an application of multi-criteria decision making (MCDM) for multi-modal fusion of features in a 3D face recognition system. A decision making process is outlined that is based on the performance of multi-modal features in a face recognition task involving a set of 3D face databases. In particular, the fuzzy interval valued MCDM technique called TOPSIS is applied for ranking and deciding on the best choice of multi-modal features at the decision stage. It provides a formal mechanism of benchmarking their performances against a set of criteria. The technique demonstrates its ability in scaling up the multi-modal features.Peer reviewedProo

    The Institutionalization of Institutional Theory

    Get PDF
    [Excerpt] Our primary aims in this effort are twofold: to clarify the independent theoretical contributions of institutional theory to analyses of organizations, and to develop this theoretical perspective further in order to enhance its use in empirical research. There is also a more general, more ambitious objective here, and that is to build a bridge between two distinct models of social actor that underlie most organizational analyses, which we refer to as a rational actor model and an institutional model. The former is premised on the assumption that individuals are constantly engaged in calculations of the costs and benefits of different action choices, and that behavior reflects such utility-maximizing calculations. In the latter model, by contrast, \u27oversocialized\u27 individuals are assumed to accept and follow social norms unquestioningly, without any real reflection or behavioral resistance based on their own particular, personal interests. We suggest that these two general models should be treated not as oppositional but rather as representing two ends of a continuum of decision-making processes and behaviors. Thus, a key problem for theory and research is to specify the conditions under which behavior is more likely to resemble one end of this continuum or the other. In short, what is needed are theories of when rationality is likely to be more or less bounded. A developed conception of institutionalization processes provides a useful point of departure for exploring this issue
    • …
    corecore